Julian Adams
Chairman
Elicio Therapeutics, Inc. (ELTX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Julian Adams
Julian Adams is recorded as Chairman at Elicio Therapeutics, Inc. (ELTX). Elicio Therapeutics, Inc. reported in an 8-K filed June 2, 2023 that Julian Adams was appointed Chair of the Board and Class III Director, effective June 1, 2023.
“Julian Adams, Ph.D., Jay R. Venkatesan, M.D. and Carol Ashe being appointed as Class III directors of the Company whose terms expire at the Company's 2026 annual meeting of stockholders, and Dr. Adams was appointed Chair of the Company's board of directors.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-06-01–present
-
Start not stated–2025-04-09
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Elicio Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Robert Connelly CEO, Chief Accounting Officer, Board Member
- Julian Adams, Ph.D. Chairman, Board Member
- Brian Piekos CFO
- Preetam Shah, Ph.D., M.B.A. CFO, Chief Accounting Officer
- Jennifer J. Rhodes General Counsel
- Allen R. Nissenson Board Member
- Allen R. Nissenson, M.D. Board Member
- Assaf Segal Board Member
- Carol Ashe Board Member
- Jay R. Venkatesan Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.